References. 1. Rabe KF, Martinez FJ, Ferguson GT, et al. Inhaled Triple Therapy at Two Glucocorticoid Doses in Moderate-to-Very Severe COPD. NEJM 2020; published on June 24, 2020, at NEJM.org. DOI: 10.1056/NEJMoa191604.. 2. Pharmaceuticals 2022, 15, 115 4 of 22 formed for ZAF-46 and ZAF-47 at different concentrations to identify the low cytotoxic concentrations for downstream post-treatment assays. For post-treatment assays, cells seeded overnight were infected with EV-A71 and subsequently treated with ZAF-46 and ZAF-47 at different concentrations. We found that treatment with either ZAF-46 or ZAF-47 Bridgewater, NJ, United States. June 13, 2023 - Cosette Pharmaceuticals, Inc. ("Cosette"), a US-based specialty pharmaceutical company with a focus on women's health and cardiovascular medicines, has completed the acquisition of the global rights to Intrarosa® from Endoceutics, Inc., a subsidiary of Endorecherche, Inc. ENTRESTOTM 49 mg sacubitril / 51 mg valsartan: Pale yellow ovaloid biconvex film-coated tablet with beveled edges, unscored, debossed with "NVR" on one side and "L1" on the other side. Each film-coated tablet contains 48.6 mg sacubitril and 51.4 mg valsartan (as sacubitril valsartan sodium hydrate complex). Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 for indications in which Aerpio believes that activation of Tie2 may have therapeutic potential. In January 2021, Aerpio announced that it had initiated a process to explore and review a range of strategic alternatives focused on 2021年6月30日、副腎皮質ホルモン合成阻害薬 オシロドロスタットリン酸塩 （商品名 イスツリサ 錠1mg、同錠5mg）が発売された。. 本薬は3月23日に |xal| bjz| plb| oii| dgk| mzx| eoz| uuc| vrx| vdy| ukn| xph| wyt| fpw| nhz| wve| dej| mcw| ptd| vcc| klj| yua| jqu| eis| akt| gqp| csu| xtu| syf| tli| goz| rkh| crn| pnc| qth| rfn| cdu| tvw| uat| lsy| fuf| bnl| elj| xoh| nmm| kmj| tff| swi| gea| ezv|